Celltrion
068270.KS
#771
Rank
$29.83 B
Marketcap
$136.36
Share price
1.48%
Change (1 day)
14.72%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): $1.89

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $1.89. an increase over its 2024 EPS that were of $1.23.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025$3.25163.66%
2024$1.23-53.73%
2023$2.66-2.08%
2022$2.72-11.72%
2021$3.082.03%
2020$3.0282.8%
2019$1.6518.31%
2018$1.40-36.33%
2017$2.19161.25%
2016$0.842.86%
2015$0.8217.84%
2014$0.695.87%
2013$0.65-70.85%
2012$2.24134.09%
2011$0.9643.59%
2010$0.6774.49%
2009$0.38317.8%
2008$0.09150-71.7%
2007$0.32